In turn, cohorts that are commonly included in genetic association studies of AD have used variable APOE genotyping methods [26–30], which has thus led to variable APOE*2/3/4 genotype quality across cohorts used in meta-analyses. The gene discussed is APOE; the disease is Alzheimer disease.